AMZN
Amazon.com, Inc.
AMZN has the edge over RDNW overall, supported by stronger valuation and stronger fundamentals.
RDNW
RideNow Group, Inc.
RDNW's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
RDNW Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
RDNW's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
RDNW PE Valuation
RDNW has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 50x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over RDNW on the outlook, with more favorable revenue expectations.
RDNW Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect RDNW to return to profit, with revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over RDNW on earnings quality, reporting a profit while its opponent remains loss making.
RDNW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.09 | — |
| Q3 2026 | -$0.47 | +$2.34 |
| Q2 2026 | -$0.22 | +$2.80 |
| Q1 2026 | -$1.23 | +$0.96 |
| Q4 2025 | -$1.38 | +$0.84 |
| Q3 2025 | -$2.81 | +$7.12 |
| Q2 2025 | -$3.02 | +$7.57 |
| Q1 2025 | -$2.19 | +$9.21 |
| Q4 2024 | -$2.22 | +$9.93 |
RDNW is still losing money, but far less than before: $0.47 per share over the past year, against $43.38 at its worst in early 2020.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over RDNW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over RDNW on profitability, with a higher operating margin.
RDNW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $244.3M | -13% |
| Q2 2026 | $296.8M | -1% |
| Q1 2026 | $260.4M | +6.4% |
| Q4 2025 | $256.9M | -4.7% |
| Q3 2025 | $281M | -4.7% |
| Q2 2025 | $299.9M | -11% |
| Q1 2025 | $244.7M | -21% |
| Q4 2024 | $269.6M | -13% |
RDNW's revenue fell from its 2022 peak and has held roughly level since: $244M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.7% | -1.6 points |
| Q2 2026 | 6% | +12 points |
| Q1 2026 | 2.9% | +1.4 points |
| Q4 2025 | 2.1% | +17 points |
| Q3 2025 | 3.4% | +1.6 points |
| Q2 2025 | -6.3% | -11 points |
| Q1 2025 | 1.6% | -0.1 points |
| Q4 2024 | -15% | +7.2 points |
RDNW's operating margin was 1.7% last quarter, down 1.6 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
RDNW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.4M | -253% |
| Q2 2026 | -$1.6M | -119% |
| Q1 2026 | -$28.2M | -$20.8M |
| Q4 2025 | -$200K | -101% |
| Q3 2025 | $9.4M | -76% |
| Q2 2025 | $8.5M | -68% |
| Q1 2025 | -$7.4M | -470% |
| Q4 2024 | $30.4M | +$55.9M |
RDNW has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over RDNW on leverage, with a lower net debt burden relative to earnings.
RDNW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.4x | High |
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 14.8x | High |
| Q4 2025 | 20.2x | High |
| Q3 2022 | 1.3x | Healthy |
| Q2 2022 | 1.1x | Healthy |
| Q1 2022 | 2.7x | Moderate |
| Q1 2021 | 96.2x | High |
RDNW's net debt is about 4.4 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
RDNW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.2 | Neutral |
| Stochastic | 13.8 | Oversold |
RDNW's weekly RSI is 44 (neutral) and its Stochastic is 14 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
RDNW PE vs Consumer Cyclical Sector
| Metric | RDNW | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
RDNW has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over RDNW on trend strength, trading above more of its moving averages.
RDNW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.23 | 10% below |
| 20 week MA | $6.35 | 26% below |
| 50 week MA | $4.35 | 8% above |
| 100 week MA | $4.49 | 4.7% above |
| 200 week MA | $7.23 | 35% below |
RDNW's trend is mixed: it's above two of its five weekly moving averages, and 35% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over RDNW on returns for 2026, with the stronger performance.
RDNW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.7 | $30.2 | +70% |
| 2021 | $30.2 | $39.7 | +31% |
| 2022 | $39.7 | $6.45 | -84% |
| 2023 | $6.45 | $8.14 | +26% |
| 2024 | $8.14 | $5.48 | -33% |
| 2025 | $5.48 | $5.30 | -3.3% |
| 2026 YTD | $5.30 | $4.70 | -11% |
RDNW has finished lower in three of the last six years. It's down 11% so far in 2026.